header
April 8, 2020

In This Issue
Maine Medical Association Zoom Meeting for Providers During COVID-19 Pandemic
Tune In to Useful Daily Updates from Maine CDC
New DEA Buprenorphine Guidance
CMS Announces Major New Flexibilities for Physicians During COVID-19 Emergency
Administration Provides Financial Relief for Medicare Providers
A Message from Maine Responds
Nominations for the MMA 2020 Mary Cushman Award for Humanitarian Service
2020-2021 MMA Medical Student Section General Council
Information about the 2020 Census
129th MAINE LEGISLATURE, SECOND REGULAR SESSION
New Law Takes Effect Concerning Physician Assistant Scope of Practice
MMA Legislative Calls are POSTPONED
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Webinar on Managing Student Debt: next Thursday April 16th 6-7pm
Building Hope Across Populations-Beyond the Basics in Suicide Prevention RESCHEDULED
Maine Suicide Prevention Program Training for Clinicians
Successful Opiate Recovery Strategies - June 3 at 2pm, Augusta Civic Center
Maine Chapter ACS Annual Conference RESCHEDULED
HEALTHCARE EMPLOYMENT OPPORTUNITIES
BC/BE Family Medicine Physician - Lovejoy Health Center
Family Medicine Outpatient Physician
Medical Director, Primary Care Physician
Physician - Nasson Health Care
Nurse Practitioner - Nasson Health Care
Psychiatric Nurse Practitioner - Nasson Health Care
Family Medicine Opportunity in Beautiful Western Maine
Orthopedic Surgeon Opportunity in Beautiful New England
VOLUNTEER OPPORTUNITIES
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health - Portland, ME

 
Search Back Issues



 

 

 


Follow Us:
New DEA Buprenorphine Guidance

]From AMA 04/02/20]

The U.S. Drug Enforcement Administration (DEA) late yesterday issued guidance to DEA-registered physicians providingnew flexibility for physicians managing patients with opioid use disorder. The new guidance permits physicians and other health professionals with a waiver allowing them to prescribe buprenorphine for the treatment of opioid use disorder to issue these prescriptions to new and existing patients based on an evaluation via telephone. The new policy is effective from March 31 for the duration of the COVID-19 emergency. 

This guidance removes a considerable barrier for many patients during the national emergency and, importantly, allows them to stay at home. The full guidance is available at: https://www.samhsa.gov/sites/default/files/dea-samhsa-buprenorphine-telemedicine.pdf.

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©